N
AMPE

Nuveen’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Nuveen’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,606
Closed -$207K – 3600
2022
Q1 		$207K Hold
1,606
– – ﹤0.01% 3188
2021
Q4 		$280K Sell
1,606
-219
-12% -$81.7K ﹤0.01% 3185
2021
Q3 		$986K Sell
1,825
-12
-0.7% -$5.56K ﹤0.01% 2991
2021
Q2 		$920K Buy
+1,837
New +$987K ﹤0.01% 3038

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen's AMPE Position: Q2 2022 in Review

Nuveen sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 1,606 shares — an estimated $207K sold.

Nuveen first reported a position in AMPE in Q2 2021 and held it in 4 quarters. The position peaked at $986K in Q3 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Nuveen reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 1,606 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $207K.
  • Nuveen first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 4 quarters.
  • Nuveen's Ampio Pharmaceuticals Inc. position peaked at $986K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.